View in EDS

Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project.

Saved in:
Bibliographic Details
Title: Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project.
Authors: Sàbat P; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Ajenjo-Bauza M; Unit of Bioinformatics for Precision Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain., Hierro C; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain., Ruffinelli JC; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Gil-Martin M; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Ochoa-de-Olza M; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain., Bergamino M; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain., Calvo M; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Soto-Castillo JJ; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Fina C; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Girona, Doctor Josep Trueta University Hospital; Girona, Spain. Precision Oncology Group (OncoGIR-Pro), Girona BiomedicaI Research Institute (IDIBGI-CERCA), Parc Hospitalari Martí i Julià, Salt, Girona, Spain., Llop S; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Stradella A; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Oliva M; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Notario L; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain., Carcereny E; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain., Teixidor-Vilà E; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Girona, Doctor Josep Trueta University Hospital; Girona, Spain. Precision Oncology Group (OncoGIR-Pro), Girona BiomedicaI Research Institute (IDIBGI-CERCA), Parc Hospitalari Martí i Julià, Salt, Girona, Spain., Domènech M; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain., Jové M; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Villanueva R; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Alay A; Unit of Bioinformatics for Precision Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain., Azuara D; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., González-Acosta M; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Otero-Torres S; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Gausachs M; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain., Varela M; Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Laboratori Core d'Anàlisi Molecular, Hospital Universitari de Bellvitge-Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain., Villatoro S; Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Laboratori Core d'Anàlisi Molecular, Hospital Universitari de Bellvitge-Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain., Solanes A; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain., Teulé A; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain., Cuadra C; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain., Moreno V; Unit of Bioinformatics for Precision Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain; Consorcio de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), Universitat de Barcelona (UB). L'Hospitalet de Llobregat, Barcelona, Spain., Nadal E; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), Universitat de Barcelona (UB). L'Hospitalet de Llobregat, Barcelona, Spain., Cordero D; Unit of Bioinformatics for Precision Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain; Consorcio de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain., Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Martin-Liberal J; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: jmartinliberal@iconcologia.net.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 May 15; Vol. 239, pp. 116728. Date of Electronic Publication: 2026 Apr 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41962211
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sàbat+P%22">Sàbat P</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ajenjo-Bauza+M%22">Ajenjo-Bauza M</searchLink>; Unit of Bioinformatics for Precision Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Hierro+C%22">Hierro C</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ruffinelli+JC%22">Ruffinelli JC</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gil-Martin+M%22">Gil-Martin M</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ochoa-de-Olza+M%22">Ochoa-de-Olza M</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bergamino+M%22">Bergamino M</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Calvo+M%22">Calvo M</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Soto-Castillo+JJ%22">Soto-Castillo JJ</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fina+C%22">Fina C</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Girona, Doctor Josep Trueta University Hospital; Girona, Spain. Precision Oncology Group (OncoGIR-Pro), Girona BiomedicaI Research Institute (IDIBGI-CERCA), Parc Hospitalari Martí i Julià, Salt, Girona, Spain.<br /><searchLink fieldCode="AU" term="%22Llop+S%22">Llop S</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Stradella+A%22">Stradella A</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Oliva+M%22">Oliva M</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Notario+L%22">Notario L</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Carcereny+E%22">Carcereny E</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Teixidor-Vilà+E%22">Teixidor-Vilà E</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Girona, Doctor Josep Trueta University Hospital; Girona, Spain. Precision Oncology Group (OncoGIR-Pro), Girona BiomedicaI Research Institute (IDIBGI-CERCA), Parc Hospitalari Martí i Julià, Salt, Girona, Spain.<br /><searchLink fieldCode="AU" term="%22Domènech+M%22">Domènech M</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute); Universitat Autònoma de Barcelona (UAB); Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Jové+M%22">Jové M</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villanueva+R%22">Villanueva R</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alay+A%22">Alay A</searchLink>; Unit of Bioinformatics for Precision Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Azuara+D%22">Azuara D</searchLink>; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22González-Acosta+M%22">González-Acosta M</searchLink>; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Otero-Torres+S%22">Otero-Torres S</searchLink>; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gausachs+M%22">Gausachs M</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Varela+M%22">Varela M</searchLink>; Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Laboratori Core d'Anàlisi Molecular, Hospital Universitari de Bellvitge-Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villatoro+S%22">Villatoro S</searchLink>; Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Laboratori Core d'Anàlisi Molecular, Hospital Universitari de Bellvitge-Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Solanes+A%22">Solanes A</searchLink>; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Teulé+A%22">Teulé A</searchLink>; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cuadra+C%22">Cuadra C</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moreno+V%22">Moreno V</searchLink>; Unit of Bioinformatics for Precision Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain; Consorcio de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), Universitat de Barcelona (UB). L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Nadal+E%22">Nadal E</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), Universitat de Barcelona (UB). L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cordero+D%22">Cordero D</searchLink>; Unit of Bioinformatics for Precision Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain; Consorcio de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lázaro+C%22">Lázaro C</searchLink>; Hereditary Cancer Program, Catalan Institute of Oncology (ICO)-Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martin-Liberal+J%22">Martin-Liberal J</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Hospitalet; L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: jmartinliberal@iconcologia.net.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2026 May 15; Vol. 239, pp. 116728. <i>Date of Electronic Publication: </i>2026 Apr 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41962211
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2026.116728
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 116728
    Titles:
      – TitleFull: Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sàbat P
      – PersonEntity:
          Name:
            NameFull: Ajenjo-Bauza M
      – PersonEntity:
          Name:
            NameFull: Hierro C
      – PersonEntity:
          Name:
            NameFull: Ruffinelli JC
      – PersonEntity:
          Name:
            NameFull: Gil-Martin M
      – PersonEntity:
          Name:
            NameFull: Ochoa-de-Olza M
      – PersonEntity:
          Name:
            NameFull: Bergamino M
      – PersonEntity:
          Name:
            NameFull: Calvo M
      – PersonEntity:
          Name:
            NameFull: Soto-Castillo JJ
      – PersonEntity:
          Name:
            NameFull: Fina C
      – PersonEntity:
          Name:
            NameFull: Llop S
      – PersonEntity:
          Name:
            NameFull: Stradella A
      – PersonEntity:
          Name:
            NameFull: Oliva M
      – PersonEntity:
          Name:
            NameFull: Notario L
      – PersonEntity:
          Name:
            NameFull: Carcereny E
      – PersonEntity:
          Name:
            NameFull: Teixidor-Vilà E
      – PersonEntity:
          Name:
            NameFull: Domènech M
      – PersonEntity:
          Name:
            NameFull: Jové M
      – PersonEntity:
          Name:
            NameFull: Villanueva R
      – PersonEntity:
          Name:
            NameFull: Alay A
      – PersonEntity:
          Name:
            NameFull: Azuara D
      – PersonEntity:
          Name:
            NameFull: González-Acosta M
      – PersonEntity:
          Name:
            NameFull: Otero-Torres S
      – PersonEntity:
          Name:
            NameFull: Gausachs M
      – PersonEntity:
          Name:
            NameFull: Varela M
      – PersonEntity:
          Name:
            NameFull: Villatoro S
      – PersonEntity:
          Name:
            NameFull: Solanes A
      – PersonEntity:
          Name:
            NameFull: Teulé A
      – PersonEntity:
          Name:
            NameFull: Cuadra C
      – PersonEntity:
          Name:
            NameFull: Moreno V
      – PersonEntity:
          Name:
            NameFull: Nadal E
      – PersonEntity:
          Name:
            NameFull: Cordero D
      – PersonEntity:
          Name:
            NameFull: Lázaro C
      – PersonEntity:
          Name:
            NameFull: Martin-Liberal J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 05
              Text: 2026 May 15
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 239
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1